RCM TECHNOLOGIES, INC. (RCMT) stock intrinsic value fair value estimate & owner earnings analysis

RCM Technologies sells specialized professionals and project services through three businesses. Specialty Health Care ($164.1 million of fiscal 2025 revenue, up 15.0%) places nurses, therapists and other clinicians, mostly with public school districts: school clients paid $141.4 million, up from $117.7 million. Engineering ($120.5 million, up 24.9%) does energy-services, aerospace and industrial work, including multiyear engineering-procurement-construction (EPC) projects for which customers pay large amounts up front. Life Sciences, Data and Solutions ($34.8 million, down 11.3%) is a smaller project and staffing business. Total revenue was $319.4 million in the 53-week fiscal 2025, with operating income of $25.1 million. How we measure the cash. We start with cash from operations, remove the swings from receivables, customer prepayments and payables (the EPC prepayments and the net payables on those projects move by $8 to $16 million a year and say nothing about earning power), subtract stock compensation as a real cost ($3.7 million in 2025), and deduct only the capital spending needed to keep the business running (about $1.4 million of the $1.6 million spent in 2025). Operating-lease bookkeeping lines offset each other and were left alone. In a few years the company's cash-flow statement shows the income-tax payable line with a sign that does not add to its own totals; we used the sign that makes the statement tie. To value the business before its lenders, we add back the interest paid and subtract the debt separately. On that basis the business produced roughly $4.3 million, $5.4 million, $6.6 million and $8.7 million in 2016 through 2019, about zero in the 2020 shutdown year, and then $9.6 million, $22.1 million, $16.0 million, $16.0 million and $21.6 million in 2021 through 2025. The normal level. We use the median of 2022 through 2025, $18.8 million a year (about $2.62 per current diluted share of 7.19 million). 2021 was the first year of the step up and the years before 2021 describe a much smaller earner. The figure sits $2.8 million below fiscal 2025, so a good year is not carried forward. For the growth path, cash for owners grew 36.8% in fiscal 2025 ($13.9 million to $19.0 million) while the base case assumes no growth and starts at $18.8 million, below that trailing rate. The first half of 2026 supports the level without moving it: revenue was up 8.7% and operating income $13.9 million against $13.2 million, though the first quarter alone was about 10% lower and the second about 20% higher. What it owes. The bank revolver stood at $23.4 million on July 4, 2026 (down from $35.0 million at the end of 2024) and finance leases were $1.2 million at the last year-end, about $24.6 million in total, or $3.42 per share. We give no credit for the $6.6 million of cash because it sits alongside large customer prepayments. The $65 million facility runs to December 3, 2029, the company reported compliance with all covenants, and $27.1 million was unused at the last year-end. The three cases. Base, $25.00 per share: the business is worth about $204.3 million, it owes $24.6 million, leaving $179.7 million. The level holds at $18.8 million for five years, which is as long as the record of this earning level runs, then fades steadily over fifteen years to about $6 million a year, the level the company earned in 2016 through 2019 (average $6.2 million) before the school and engineering surge, and stays there. We credit no growth. School revenue rose 20% in 2025, aerospace added $11.9 million with new clients and EPC activity increased, but staffing has no durable protection and none of that is contracted forward, so it is left out. The Germany contract pipeline that prompted the larger credit line is unsigned and also left out. Bear, $8.79: the business is worth about $87.8 million, it owes $24.6 million, leaving $63.2 million. Two school customers were 20.8% and 13.6% of 2025 revenue (34.4% together) and the five largest were 51.0%. The case assumes the largest relationship is lost or repriced, taking cash to $14 million in year one, $9 million in year two and $6 million in years three and four, then repeats the 2020 shutdown: that year revenue fell 21% to $150.4 million and the company lost $10.95 million at the operating line after a $7.9 million receivables provision. The case shows no cash in year five and $3 million in year six, then $6 million through year ten, and afterwards $4.3 million a year, the weakest of the 2016 through 2019 years. In the zero year the business covers neither its interest bill of roughly $1.5 to $2.0 million nor anything else, which the revolver availability can carry for a year. The case gives no credit for the receivables that collect in a downturn (in 2020 operating cash flow was $25.2 million despite the loss), a cushion that is real but excluded. Bull, $35.94: the business is worth about $282.9 million, it owes $24.6 million, leaving $258.3 million. Starting from $22.0 million, essentially the fiscal 2025 level with the first half of 2026 running slightly ahead, cash grows 4%, 4%, 3%, 3% and 2% in years two to six, below the 6.8% annual revenue growth since 2016, then holds flat through year ten and fades over fifteen years to $6 million. Each dollar of added revenue is charged $0.25 of extra working capital, above the roughly $0.18 the company has actually absorbed since 2020. Testing the case. Gross margins slipped (Specialty Health Care 29.8% to 28.9%, Engineering 23.4% to 22.7%) and corporate costs rose 14% to $18.0 million; the normal level already sits below fiscal 2025 and that covers it. The share count has fallen by more than a third since 2020, partly funded by borrowing, which flatters per-share trends but not the business totals we use. If the true normal level were the five-year median of $16.0 million rather than $18.8 million, the base case would be about $21.84; if nothing at all persisted beyond year twenty, about $20.66; if the bear case's long-run $4.3 million did not persist, the bear case would be about $3.22. The previous analysis of August 31, 2026 was built on a different basis and its figures are not comparable; no new annual or quarterly filing has appeared since. The margin-of-safety price, $12.00. We are reasonably but not fully sure of the earnings level: four straight years of operating income between $22.3 million and $28.8 million support it, but a third of revenue sits with two school customers and the same business earned about a third as much in 2016 through 2019 and lost money in 2020. The worst plausible event is the largest customer (about $66 million of revenue, perhaps $19 million of gross profit at the segment's margin, our estimate) leaving during a downturn. The structure would survive that: debt is about 1.3 times a normal year's cash before interest, there is no plant to finance, and the shares, not the lenders, absorb the loss. If we are wrong about the level the base falls to about $21.84, and if the bear case plays out the shares are worth about $8.79. The price assumes a three-to-five-year holding period. The credit agreement restricts dividends, so cash reaches shareholders through debt repayment and buybacks ($7.4 million in 2025) rather than dividends. At $12.00 the shares plus $24.6 million of debt value the whole business at about $111 million, or 5.9 times a normal year's cash before interest, and the cash left for owners after interest at the normal level is about $2.25 per share, 18.8% of that price, building up inside the business over the holding period. That is the price at which a few years of flat earnings alone implies roughly the 20% target, while the bear case implies a loss to $8.79; a higher price would require counting on growth we cannot name and evidence.